Joseph Zielinski

Title: Joseph Zielinski: Innovator in Active Agent Delivery Systems

Introduction

Joseph Zielinski is a notable inventor based in Florham Park, NJ (US). He has made significant contributions to the field of active agent delivery systems, holding a total of 5 patents. His work focuses on enhancing the efficacy of delivery agents through innovative chemical formulations.

Latest Patents

One of Zielinski's latest patents involves the development of disodium salts, monohydrates, and ethanol solvates for delivering active agents. The inventors discovered that the disodium salt of certain delivery agents exhibits surprisingly greater efficacy for delivering active agents compared to the corresponding monosodium salt. Additionally, they found that these disodium salts form solvates with ethanol and hydrates with water. Preferred delivery agents in this invention include N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC), N-(10-[2-hydroxybenzoyl]amino)decanoic acid (SNAD), and sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC). The invention also outlines methods for preparing the disodium salt, ethanol solvate, and hydrate, along with compositions containing these elements.

Career Highlights

Throughout his career, Joseph Zielinski has worked with prominent companies such as Novartis AG and Emisphere Technologies, Inc. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.

Collaborations

Zielinski has collaborated with notable professionals in his field, including Rajesh K Agarwal and Kiran Chaudhary. These collaborations have further enriched his research and development efforts.

Conclusion

Joseph Zielinski's innovative work in the area of active agent delivery systems has led to significant advancements in pharmaceutical technology. His contributions continue to influence the effectiveness of drug delivery methods, showcasing the importance of innovation in healthcare.